Physician profile
Mark Suh
NPI 1548849227
$1,199.21
in general payments reported to CMS, 2019-2025
18 companies · $949 in 2025
The $949 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $32.19 · 2023: $54.11 · 2024: $164 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $278.58 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Dexcom, INC. | $98.36 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $98.16 | 2025 | |
| Glaxosmithkline, LLC. | $87.80 | 2024-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $87.53 | 2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $70.95 | 2023-2025 | Repatha, Otezla, Repatha |
| Shield Therapeutics INC | $69.33 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $68.24 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $65.02 | 2024-2025 | Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $58.82 | 2024-2025 | Capvaxive, Gardasil 9, Lagevrio |
| Abbvie INC. | $40.38 | 2023 | Avycaz, Teflaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.57 | 2025 | Jardiance |
| Alexion Pharmaceuticals, INC. | $32.19 | 2022 | |
| Sanofi Pasteur INC. | $26.03 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $25.41 | 2025 | Neffy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $22.61 | 2025 | |
| Integra Lifesciences Corporation | $21.07 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Exact Sciences Corporation | $16.16 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Suh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.